secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001185185-24-000324
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma announces $3M private placement with Bradbury Asset Management at $0.34/share
--------------------------------------------------------------------------------

- Issued 8,823,529 unregistered common shares at $0.34/share to Bradbury Asset Management on March 22, 2024.
- Gross proceeds of $3 million to fund general corporate purposes and advance investigational drug IGC-AD1.
- Closing subject to customary conditions including NYSE approval; shares not immediately tradable.
- After issuance, IGC will have ~75,365,061 shares outstanding; piggyback registration rights granted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518524000324/0001185185-24-000324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518524000324/igcpharma20240326_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-24-000324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer